Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
17.24
+0.22 (1.29%)
At close: Aug 28, 2025, 4:00 PM
17.23
-0.01 (-0.06%)
After-hours: Aug 28, 2025, 7:59 PM EDT
Oscar Health Stock Forecast
Stock Price Forecast
The 7 analysts that cover Oscar Health stock have a consensus rating of "Sell" and an average price target of $12.07, which forecasts a -29.99% decrease in the stock price over the next year. The lowest target is $10 and the highest is $14.
Price Target: $12.07 (-29.99%)
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for Oscar Health stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 1 | 1 | 0 |
| Hold | 3 | 3 | 3 | 2 | 1 | 2 |
| Sell | 2 | 2 | 2 | 2 | 4 | 4 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 8 | 8 | 8 | 5 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $14 → $13 | Hold | Maintains | $14 → $13 | -24.59% | Aug 14, 2025 |
| Baird | Baird | Buy → Hold Downgrades $28 → $14 | Buy → Hold | Downgrades | $28 → $14 | -18.79% | Jul 25, 2025 |
| Barclays | Barclays | Sell Maintains $17 → $11 | Sell | Maintains | $17 → $11 | -36.19% | Jul 23, 2025 |
| UBS | UBS | Hold → Strong Sell Downgrades $15 → $11 | Hold → Strong Sell | Downgrades | $15 → $11 | -36.19% | Jul 15, 2025 |
| Wells Fargo | Wells Fargo | Hold → Sell Downgrades $16 → $10 | Hold → Sell | Downgrades | $16 → $10 | -42.00% | Jul 11, 2025 |
Financial Forecast
Revenue This Year
12.30B
from 9.18B
Increased by 33.98%
Revenue Next Year
11.53B
from 12.30B
Decreased by -6.26%
EPS This Year
-1.37
from 0.10
EPS Next Year
-0.16
from -1.37
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 12.7B | 12.7B | |
| Avg | 12.3B | 11.5B | |
| Low | 11.8B | 10.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 38.6% | 3.6% | |
| Avg | 34.0% | -6.3% | |
| Low | 28.1% | -13.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.23 | 1.03 | |
| Avg | -1.37 | -0.16 | |
| Low | -1.44 | -0.91 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.